NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inventia Life Science

Inventia Life Science

Private
AlexandriaHealthcare & Life Scienceshttps://inventialifescience.com/

Last Round

VC Round

Apr 24, 2025

Total Funding Raised

$37.52M

Company Overview

Inventia Life Science is a biotechnology company that develops and manufactures 3D bioprinting platforms, including printers and bio-inks, to create advanced cell models for biomedical research and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, 3D Printing, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

3D bioprinting3D cell culturedrug discoverybiotech equipmentorgan-on-a-chiphigh-throughput screeningcontract research organizationCROsynthetic hydrogelsbio-inksdisease modelinglab automationprecision medicinein vitro testingbiotech lab tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inventia Life Science Comparables

Compare Inventia Life Science with similar companies based on industry and business-model similarity.

Inventia Life Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VoxCell BioInnovation
86%
MIMETAS
83%
Aspect Biosystems
83%

Inventia Life Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 24, 2025
VC RoundJan 1, 2023
Series B ExtensionJun 1, 2022
Series BDec 15, 2021
GrantJul 31, 2020
Series A
Nov 27, 2018

Key People

Founding team and executive leadership

Aidan O'Mahony

Founder CTO

Founding Team

Cameron Ferris

Co-Founder Chief Operating Officer

Founding Team

Darren Bailey

Chief Financial Officer

Executive Team

Bob Groneman

Chief Product Officer

Executive Team

Inventia Life Science Investors

Notable investors and investment history

Inventia Life Science investors
InvestorRounds
Skip CapitalSeries B, Series A
AirTreeSeries A
Australian GovernmentGrant
Blackbird VenturesSeries B, Seed, Series A
TenmileVC Round
Main Sequence VenturesSeries A
HESTA Industry Super FundSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2021

    $25M round led by Blackbird Ventures

  • Jul 31, 2020

    $720K grant received from the Australian Government.

Inventia Life Science Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inventia Life Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inventia Life Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlexandria
Employee Range62
Year Founded2013
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.